Core Insights - The trend of "makeup and medical integration" is gaining significant attention in the beauty industry, with major brands accelerating their entry into the medical aesthetics sector [1][5] - The medical aesthetics market is viewed as a new growth driver, despite the current early-stage development of the interaction between beauty and medical aesthetics [1][5] Industry Developments - Leading beauty brands are actively investing in the medical aesthetics sector, with various strategies such as investing in upstream research and launching related medical brands or products [2][3] - Notable actions include Shiseido's announcement of its first medical beauty brand in China, L'Oréal's strategic partnership with Tru Diagnostic, and Estée Lauder's collaboration with Jia Hui Medical in Shanghai [2][3] Domestic Market Movements - Domestic brands like Marubi and Gu Yu are also making significant moves in the medical aesthetics space, with Marubi investing in a medical materials R&D company and Gu Yu collaborating with a research institute to explore innovative medical products [3] - Other domestic brands such as Pechoin, Aimeike, and Furuida are also accelerating the integration of medical aesthetics and beauty [3] Market Potential - The medical aesthetics market in China is expected to reach a scale of 381.6 billion to 410.8 billion yuan by 2025, making it a crucial growth area globally [5][6] - The overlap between beauty and medical aesthetics consumer groups is driving beauty companies to enter the medical aesthetics market [5][6] Competitive Landscape - Differentiation is key for brands looking to penetrate the medical aesthetics market, as the sector faces high regulatory barriers and technical challenges [6][7] - The current market primarily features Class II medical devices, with brands focusing on consumer needs during the perioperative period of medical aesthetics [6] Industry Trends - The integration of beauty and medical aesthetics is reshaping the competitive landscape, with both domestic and international brands needing to adapt to a market transitioning from rapid growth to stable development [7] - The industry is undergoing a significant reshuffle, emphasizing the need for brands to balance consumer demand with the rigor of medical standards [7]